Navigation Links
Channel Islands Alzheimer's Institute Receives $120,000 Donation
Date:10/17/2007

CAMARILLO, Calif., Oct. 17 /PRNewswire/ -- The Channel Islands Alzheimer's Institute recently received a $120,000 donation from Cardax Pharmaceuticals. The money will be received in four payments of $30,000 each beginning now through 2008.

The Channel Islands Alzheimer's Institute is located on the campus of California State University Channel Islands.

Included in the $120,000 donation are at least two student research scholarships for $6,000 each to be used for the student recipients' fees and expenses over two semesters.

"We are gratified that Cardax Pharmaceuticals saw the potential in the drug discovery work of our institute," said Gilbert M. Rishton, Ph.D., founding scientist and director of the Channel Islands Alzheimer's Institute. "These funds will support our ongoing work in drug discovery for neurodegeneration and on the role that certain dietary antioxidants might play in the prevention of cognitive decline and Alzheimer's disease".

Cardax Pharmaceuticals, located in Aiea, Hawaii, develops antioxidant compounds as drug candidates for cardiovascular and inflammatory disease. Cardax Pharmaceuticals has identified a potent antioxidant found in krill and wild salmon, astaxanthin, as being effective in models of cardiovascular and inflammatory disease. The Cardax Pharmaceutical drug candidate is a novel and improved derivative of astaxanthin that is poised for human testing in 2008.

The Channel Islands Alzheimer's Institute has been created to conduct drug discovery research, potentially toward a treatment for the disease that has become so prevalent throughout the world today. According to the Alzheimer's Association, it is estimated that nearly 14 million people worldwide currently suffer from Alzheimer's Disease. By 2050, that number is expected to increase to 45 million. The Channel Islands Alzheimer's Institute will provide opportunities for faculty and students to discover new chemical compounds that will inhibit the neurodegenerative component of Alzheimer's disease.

For more information on the Channel Islands Alzheimer's Institute, its projects and science, contact Gilbert M. Rishton, founding scientist, by e- mail, gilbert.rishton@csuci.edu.

For media inquires about this donation or the Channel Islands Alzheimer's Institute contact Ceal Potts, communications specialist at CSUCI, 805-437-8940 or cecilia.potts@csuci.edu.

This press release was issued through 24-7PressRelease.com. For further information, visit http://www.24-7pressrelease.com.


'/>"/>
SOURCE Channel Islands Alzheimer's Institute
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Feeding channel created by malaria parasite - a new target for malaria treatments
2. A Call To Open Up The Channel Of Goodwill To Rescue The Dying Hearts
3. PharmaVentures Exploits Fastest Growing Media Channel to Launch First Pharmaceutical Business Television Show
4. New Way to Open Cellular Ion Channels, Implications for Drug Design
5. Altered Sodium Channel Function Linked to Heart Failure
6. How Ion Channels are Organized to Control Nerve Cell Communication?
7. Brain Networks Strengthened by Closing Ion Channels
8. Australian TV Channel to Study Breast Cancer Incidence in Its Women Staff
9. Scientists Find Single Circuit Channeling Depression in Rats
10. Phoenix Islands To Be Protected Under Global Conservation Map
11. Testing genes for disease does not cause harm to children of people with Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/24/2017)... ... September 24, 2017 , ... “Star of Bethlehem Study”: is a thought-provoking ... the creation of published author, Duane Engdahl, an investigator who had has a long ... Duane Engdahl’s new book is a thought-provoking essay an event so significant that it ...
(Date:9/23/2017)... San Francisco, CA (PRWEB) , ... September 23, 2017 , ... ... Bay Area, is proud to announce a new blog post focused on the ARTAS® ... loss, they understandably hope to turn to the latest, most technologically sophisticated methods of ...
(Date:9/22/2017)... , ... September 22, 2017 , ... On Sunday, September ... and 5K honoring Olympian, Florence Joyner, still considered the fastest woman of all time. ... Flo Jo’s daughter, Mary Joyner, will sing the National Anthem. Mary was a ...
(Date:9/22/2017)... ... September 22, 2017 , ... Ecocor ... Richard Pedranti Architect (RPA), a full-service architecture firm focusing on sustainable ... Solsken Line of Model Homes . Independently, Ecocor and RPA have extensive experience ...
(Date:9/22/2017)... ... 2017 , ... SABRE is pleased to announce the ... a graduate student from Sonora, California, who will begin her studies this fall ... in Miami, Florida, was selected from a pool of more than 50,000 applicants ...
Breaking Medicine News(10 mins):
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
(Date:9/7/2017)... -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a ... will be participating in the Morgan Stanley 15 th ... hotel in New York.  Zimmer Biomet will present on ... A live webcast of the presentation can ... http://investor.zimmerbiomet.com .   ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
Breaking Medicine Technology: